Barclays 27 (FN36) News

A Direct program is useless unless MHRA approves L. And direct is useless without renewed medical trials which cost at least $150 million if not more. Therefore IMO NWBO is anticipating a cash injection (hopefully non dilutive from a big pharma) and is expecting approval soon.

muln.............................................A/H

Patience is the key! GLTA $CGAC

Now, this is all agreed on all fronts, which makes total sense.

actually hit .001

MULN: May I conclude then, Young Lady, that you simply do NOT like this firm from any conceivable perspective???

https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExaXBrNTc1NHBoZWR4bXB1c29wcGRsbTh2emF3cDB1d2p6OHA2eW53ZyZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9cw/a8uMrItvbj46A9bhud/giphy.gif

~~COMPX 11/13/2024~~~~~~~

Previous Close

19,281.40 -17.36

19199 SSKILLZ1

LOL I learned how to play golf while everyone else was trying out for the football team.. I found out that I didn't belong there either but they liked the drugs I got them and going to rock concerts all night.

Spot on

It’s developed. It needs to be trialed.

I take Seeking alpha with a grain of salt. Just relaying new info (good or bad). Hopefully - this will be good. The points raised in the articles however are legit and make sense to me.

I’d speculate the completed contracts are with Merck and Oncovir. Just a guess based on Keytruda and Poly-iclc trials with DCVax-l.

Yeh, no confidence at all but that's certainly the ring I'd throw my hat in if I had to.

Diddy and Epstein lists are coming soon to a theater near you. Videos are included.

Wait till you all find out who is on them. I can tell you right now, they are all Kamala supporters. And yes there are RINO's included. Many will try to leave the country but will be taken into custody

Direct to start by end of January so perhaps not a lengthy delay.

MULN...........................................a/h
https://www.stockscores.com/charts/charts/?ticker=MULN

My guess is Ward has sent out multiple thumbs up in the last 12 hrs and things are good..Better than good...👍

Thanks that is interesting. However, how on earth they will be able to finance a DCVAX Direct medical trial is beyond me. Hopefully, a large pharma will inject a boa load of cash in NWBO. Also if MHRA does not approve then the DCVax-Direct program would be worthless therefore apparently NWBO expect

Prep to restart Direct:
So they are paying Advent to develop a new version of Direct. Not even in the clinic yet. Maybe they are looking for something better than a 0.0% ORR that the original Direct showed.

More incompetence from Sharp.

Nothing new.

This fraudulent garbage about to hit the trips. Promoters got better plays to pump elsewhere.

Your charting is worth looking at,Steve.
You were right about the rally.But it's looking like 10 might be the peak at the moment. It would be a double from the 5 bottom. Seems noteworthy to me. Avxl tends to retrace to the lower targets, which might be around 7 dollars , in this pattern. Som

Q10: The companies are particularly focusing on trial designs in which the primary endpoint will be tumor response (shrinkage), with potential timeframes in months, rather than time-to-event survival outcomes, with timeframes in years. The Company anticipates potentially being ready to submit an IND